Enveric Biosciences, Inc.

Enveric Biosciences is a biotechnology company focused on developing novel neuroplastogenic small-molecule therapeutics for the treatment of neuropsychiatric disorders. Their primary focus is on depression, anxiety, and addiction disorders. Enveric leverages their unique discovery and development platform, called the Psybrary™, which has generated a robust intellectual property portfolio of new chemical entities designed for specific mental health indications. Their lead program, EB-003, is a first-in-class approach to treating these disorders, designed to promote neuroplasticity without inducing hallucinations.

Enveric Biosciences is also developing EB-002, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment for psychiatric disorders. In addition to their internal development, they also actively pursue out-licensing opportunities with strategic partners to diversify their portfolio and potential revenue streams. Their commitment to developing non-hallucinogenic treatments that can be administered orally offers the potential for more patient-friendly and accessible therapies for a wide range of mental health conditions.

Enveric Biosciences is a biotechnology company dedicated to developing novel neuroplastogenic small-molecule therapeutics for treating neuropsychiatric disorders like depression, anxiety, and addiction. They leverage their unique drug discovery and development platform, The Psybrary™, to create a robust intellectual property portfolio of new chemical entities specifically targeting mental health indications. Their primary focus is on developing treatments that promote neuroplasticity without inducing hallucinations, aiming to create a new generation of safer and more effective therapies for mental health conditions.

Enveric Biosciences fosters a culture of innovation and collaboration, driven by a commitment to developing novel therapies for mental health disorders. The company values a team-oriented approach, leveraging the expertise of seasoned life sciences professionals and scientific advisors to advance its research and development efforts. Enveric encourages open communication and a collaborative environment, fostering a spirit of discovery and a shared passion for improving patient lives.

Enveric Biosciences demonstrates a commitment to diversity, equity, and inclusion by actively seeking a diverse Board of Directors, promoting a diverse management team and engaging with leading experts in the field to ensure its scientific advisory board reflects the diversity of its stakeholders. The company acknowledges that diversity in leadership and expertise is essential for innovation and success in the field of mental health research.